Apps listed551,995Added in 24 h16,201Apps mentioned on AVALW3,945AVALW article mentions17,994

J3M-MC-JZQB CN

Health & Fitness

Medable, Inc.

iPhone iPad AndroidFree
Store rating
-
Store ratings
-
AVALW mentions
0
Price
Free
Platforms
3
Listed
Nov 19, 2026

Screenshots

J3M-MC-JZQB CN screenshot 1J3M-MC-JZQB CN screenshot 2J3M-MC-JZQB CN screenshot 3J3M-MC-JZQB CN screenshot 4

About J3M-MC-JZQB CN

A Multicenter, Randomized, Phase 3 Study Comparing LY3537982 and Pembrolizumab to Placebo and Pembrolizumab as First-Line Treatment in Patients with KRAS G12C-Mutant, Locally Advanced or Metastatic Non-Small Cell Lung Cancer with High PD-L1 Expression (TPS ≥ 50%). This app is specifically intended for participants in the J3M-MC-JZQB study only.

AVALW Coverage

Not yet mentioned in AVALW articles.